Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;9(2):361–368. doi: 10.1111/j.1750-3639.1999.tb00232.x

Paraproteinaemic Neuropathies

Andreas J Steck 1,✉, Beat Erne 2, Jean‐Marc Gabriel 2,*, Nicole Schaeren‐Wiemers 2
PMCID: PMC8098558  PMID: 10219751

Abstract

In this article, we review the main clinical and pathological features of paraproteinaemic neuropathies and discuss recent experimental findings. Further knowledge of the disease process at the molecular level has allowed a better characterization of clinical syndromes and has given new insights into their pathogenesis. The most convincing evidence for a causal relationship can be drawn from IgM monoclonal gammopathies with specificities directed against carbohydrate determinants of the myelin associated glycoprotein (MAG). There remain however, many unresolved questions, such as how monoclonal anti‐MAG IgM antibodies cross the blood‐nerve barrier and trigger a chronic demyelinating polyneuropathy while the central nervous system is essentially spared. IgM paraproteins with specificity for other molecules, such as neurofilaments, sulphatide, gangliosides, chondroitin sulphate and tubulin, have also been identified, but their pathogenetic importance remains to be elucidated.

Other paraproteinaemic neuropathies such as IgG and IgA neuropathies have to be considered separately. The paraneoplastic endocrine and cytokine manifestations of rare osteosclerotic myelomas provide valuable insights into the interaction between the immune and the nervous system. The antigen‐specificity of IgG and IgA monoclonal antibodies are only poorly characterized but some have been found to be directed against endoneurial determinants and a few against axonal proteins such as neurofilaments.

Full Text

The Full Text of this article is available as a PDF (110.3 KB).

References

  • 1. Agnello V, Chung RT, Kaplan LM (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327: 1490–1495. [DOI] [PubMed] [Google Scholar]
  • 2. Barbieri S, Nobile‐Orazio E, Baldini L, Fayoumi Z, Manfredini E, Scarlato G (1987) Visual evoked potentials in patients with neuropathy and macroglobulinemia. Ann Neurol 22: 663–666. [DOI] [PubMed] [Google Scholar]
  • 3. Braun PE, Frail DE, Latov N (1982) Myelin‐associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem 39: 1261–1265. [DOI] [PubMed] [Google Scholar]
  • 4. Bromberg MB, Feldman EL, Albers JW (1992) Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy. Neurology 42: 1157–1163. [DOI] [PubMed] [Google Scholar]
  • 5. Burger D, Pidoux L, Steck AJ (1993) Identification of the glycosylated sequence of human myelin‐associated glycoprotein. Biochem Biophys Res Commun 197: 457–464. [DOI] [PubMed] [Google Scholar]
  • 6. Caligaris‐Cappio F, De Leo AM, Bertero MT (1997) Autoimmune phenomena and hepatitis C virus in lympho‐proliferative and connective tissue disorders. Leuk Lymphoma 28: 57–63. 9498704 [Google Scholar]
  • 7. Chad D, Pariser K, Bradley WG, Adelman LS, Pinn VW (1982) The pathogenesis of cryoglobulinemic neuropathy. Neurology 32: 725–729. [DOI] [PubMed] [Google Scholar]
  • 8. Chassande B, Leger JM, Younes‐Chennoufi AB, Bengoufa D, Maisonobe T, Bouche P, Baumann N (1998) Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M‐protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve 21: 55–62. [DOI] [PubMed] [Google Scholar]
  • 9. Ellie E, Vital A, Steck A, Boiron JM, Vital C, Julien J (1996) Neuropathy associated with “benign” anti‐myelin‐associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases. J Neurol 243: 34–43. [DOI] [PubMed] [Google Scholar]
  • 10. Fahrig T, Landa C, Pesheva P, Kuhn K, Schachner M (1987) Characterization of binding properties of the myelin‐associated glycoprotein to extracellular matrix constituents. EMBO J6: 2875–2883. [DOI] [PMC free article] [PubMed]
  • 11. Freddo L, Ariga T, Saito M, Macala LC, Yu RK, Latov N (1985) The neuropathy of plasma cell dyscrasia: binding of IgM M‐proteins to peripheral nerve glycolipids. Neurology 35: 1420–1424. [DOI] [PubMed] [Google Scholar]
  • 12. Gabriel JM, Erne B, Bernasconi L, Tosi C, Probst A, Landmann L, Steck AJ (1998) Confocal microscopic localization of anti‐MAG autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy. Acta Neuropathol 95: 540–546. [DOI] [PubMed] [Google Scholar]
  • 13. Gabriel JM, Erne B, Miescher GC, Miller SL, Vital A, Vital C, Steck AJ (1996) Selective loss of myelin‐associated glycoprotein from myelin correlates with anti‐MAG antibody titre in demyelinating paraproteinaemic polyneuropathy. Brain 119: 775–787. [DOI] [PubMed] [Google Scholar]
  • 14. Garcin R, Mallarmé J, Rondot P (1958) Forme neuritique de la macroglobulinémie de Waldenström. Bull Soc Med (Paris) 74: 562. [PubMed] [Google Scholar]
  • 15. Gemignani F, Pavesi G, Fiocchi A, Manganelli P, Ferraccioli G, Marbini A (1992) Peripheral neuropathy in essential mixed cryoglobulinaemia. J Neurol Neurosurg Psychiatry 55: 116–120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Gherardi RK, Belec L, Fromont G, Divine M, Malapert D, Gaulard P, Degos JD (1994) Elevated levels of interleukin‐1 beta (IL‐1 beta) and IL‐6 in serum and increased production of IL‐1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood 83: 2587–2593. [PubMed] [Google Scholar]
  • 17. Gherardi RK, Belec L, Soubrier M, Malapert D, Zuber M, Viard JP, Intrator L, Degos JD, Authier FJ (1996) Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood 87: 1458–1465. [PubMed] [Google Scholar]
  • 18. Gosselin S, Kyle RA, Dyck PJ (1991) Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 30: 54–61. [DOI] [PubMed] [Google Scholar]
  • 19. Hammer JA, OS DJ, De Leon M, Gould R, Zand D, Daune G, Quarles RH (1993) Immunoreactivity of PMP‐22, P0, and other 19 to 28 kDa glycoproteins in peripheral nerve myelin of mammals and fish with HNK1 and related antibodies. J Neurosci Res 35: 546–558. [DOI] [PubMed] [Google Scholar]
  • 20. Ilyas AA, Quarles RH, Dalakas MC, Fishman PH, Brady RO (1985) Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann Neurol 18: 655–659. [DOI] [PubMed] [Google Scholar]
  • 21. Jacobs JM (1996) Morphological changes at paranodes in IgM paraproteinaemic neuropathy. Microsc Res Tech 34: 544–553. [DOI] [PubMed] [Google Scholar]
  • 22. Jacobs JM, Scadding JW (1990) Morphological changes in IgM paraproteinaemic neuropathy. Acta Neuropathol (Berl) 80: 77–84. [DOI] [PubMed] [Google Scholar]
  • 23. Jungalwala FB (1994) Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system. Neurochem Res 19: 945–957. [DOI] [PubMed] [Google Scholar]
  • 24. Kaku DA, England JD, Sumner AJ (1994) Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin‐associated glycoprotein and sulphated glucuronyl paragloboside. Brain 117: 941–947. [DOI] [PubMed] [Google Scholar]
  • 25. Kelly JJ, Adelman LS, Berkman E, Bhan I (1988) Polyneuropathies associated with IgM monoclonal gammopathies. Arch Neurol 45: 1355–1359. [DOI] [PubMed] [Google Scholar]
  • 26. Khella SL, Frost S, Hermann GA, Leventhal L, Whyatt S, Sajid MA, Scherer SS (1995) Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review. Neurology 45: 407–411. [DOI] [PubMed] [Google Scholar]
  • 27. King RH, Thomas PK (1984) The occurrence and significance of myelin with unusually large periodicity. Acta Neuropathol (Berl) 63: 319–329. [DOI] [PubMed] [Google Scholar]
  • 28. Kinsella LJ, Lange DJ, Trojaborg W, Sadiq SA, Younger DS, Latov N (1994) Clinical and electrophysiologic correlates of elevated anti‐GM1 antibody titers. Neurology 44: 1278–1282. [DOI] [PubMed] [Google Scholar]
  • 29. Kruse J, Mailhammer R, Wernecke H, Faissner A, Sommer I, Goridis C, Schachner M (1984) Neural cell adhesion molecules and myelin‐associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK‐1. Nature 311: 153–155. [DOI] [PubMed] [Google Scholar]
  • 30. Lamarca J, Casquero P, Pou A (1987) Mononeuritis multiplex in Waldenstrom's macroglobulinemia. Ann Neurol 22: 268–272. [DOI] [PubMed] [Google Scholar]
  • 31. Latov N, Sherman WH, Nemni R, Galassi G, Shyong JS, Penn AS, Chess L, Olarte MR, Rowland LP, Osserman EF (1980) Plasma‐cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral‐nerve myelin. N Engl J Med 303: 618–621. [DOI] [PubMed] [Google Scholar]
  • 32. Li F, Pestronk A, Griffin J, Feldman EL, Cornblath D, Trotter J, Zhu S, Yee WC, Phillips D, Peeples DM, et al. (1991) Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin‐associated glycoprotein. Neurology 41: 357–362. [DOI] [PubMed] [Google Scholar]
  • 33. Martini R (1994) Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. J Neurocytol 23:1–28. [DOI] [PubMed] [Google Scholar]
  • 34. Miralles GD, OF JR, Talley NJ (1992) Plasma‐cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med 327: 1919–1923. [DOI] [PubMed] [Google Scholar]
  • 35. Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardieri S, Bordin G, et al. (1995) Cryoglobulinaemias: a multi‐centre study of the early clinical and laboratory manifestations of primary and secondary disease. Q J Med 88: 115–126. [PubMed] [Google Scholar]
  • 36. Murray N, Page N, Steck AJ (1986) The human antimyelin‐associated glycoprotein IgM system. Ann Neurol 19: 473–478. [DOI] [PubMed] [Google Scholar]
  • 37. Nemni R, Corbo M, Fazio R, Quattrini A, Comi G, Canal N (1988) Cryoglobulinaemic neuropathy. A clinical, morphological and immunocytochemical study of 8 cases. Brain 111: 541–552. [DOI] [PubMed] [Google Scholar]
  • 38. Nobile‐Orazio E (1998) Neuropathies associated with anti‐MAG antibodies and IgM monoclonal gammopathies. In: Immunological and Infectious Diseases of the Peripheral Nerve, Latov N., Wokke J. and Kelly J., (Eds.), pp. 168–189. University Press, Cambridge . [Google Scholar]
  • 39. Nobile‐Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, Bonetti B, Cavaletti G, Gemignani F, Durelli L, et al. (1994) Frequency and clinical correlates of anti‐neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 36: 416–424. [DOI] [PubMed] [Google Scholar]
  • 40. Nobile‐Orazio E, Marmiroli P, Baldini L, Spagnol G, Barbieri S, Moggio M, Polli N, Polli E, Scarlato G (1987) Peripheral neuropathy in macroglobulinemia: incidence and antigen‐specificity of M proteins. Neurology 37: 1506–1514. [DOI] [PubMed] [Google Scholar]
  • 41. O'Shannessy DJ, Willison HJ, Inuzuka T, Dobersen MJ, Quarles RH (1985) The species distribution of nervous system antigens that react with anti‐myelin‐associated glycoprotein antibodies. J Neuroimmunol 9: 255–268. [DOI] [PubMed] [Google Scholar]
  • 42. Ogino M, Tatum AH, Latov N (1994) Affinity studies of human anti‐MAG antibodies in neuropathy. J Neuroimmunol 52: 41–46. [DOI] [PubMed] [Google Scholar]
  • 43. Pesheva P, Horwitz AF, Schachner M (1987) Integrin, the cell surface receptor for fibronectin and laminin, expresses the L2/HNK‐1 and L3 carbohydrate structures shared by adhesion molecules. Neurosci Lett 83: 303–306. [DOI] [PubMed] [Google Scholar]
  • 44. Quattrini A, Corbo M, Dhaliwal SK, Sadiq SA, Lugaresi A, Oliveira A, Uncini A, Abouzahr K, Miller JR, Lewis L, et al. (1992) Anti‐sulfatide antibodies in neurological disease: binding to rat dorsal root ganglia neurons. J Neurol Sci 112: 152–159. [DOI] [PubMed] [Google Scholar]
  • 45. Raine CS, Bornstein MB (1979) Experimental allergic neuritis. Ultrastructure of serum‐induced myelin aberrations in peripheral nervous system cultures. Lab Invest 40: 423–432. [PubMed] [Google Scholar]
  • 46. Sindic CJ, Boucquey D, Bisteau M, Laloux P, Brucher JM, Laterre C (1989) Monoclonal IgM gammopathy with anti‐myelin associated glycoprotein (MAG) activity and polyneuropathy. A study of three cases. Acta Neurol Belg 89: 331–345. [PubMed] [Google Scholar]
  • 47. Smith IS, Kahn SN, Lacey BW, King RH, Eames RA, Whybrew DJ, Thomas PK (1983) Chronic demyelinating neuropathy associated with benign IgM parapro‐teinaemia. Brain 106: 169–195. [DOI] [PubMed] [Google Scholar]
  • 48. Snipes GJ, Suter U, Shooter EM (1993) Human peripheral myelin protein‐22 carries the L2/HNK‐1 carbohydrate adhesion epitope. J Neurochem 61: 1961–1964. [DOI] [PubMed] [Google Scholar]
  • 49. Steck AJ, Adams D (1991) Motor neuron syndromes and monoclonal IgM antibodies to gangliosides. Adv Neurol 56:421–425. [PubMed] [Google Scholar]
  • 50. Steck AJ, Murray N, Meier C, Page N, Perruisseau G (1983) Demyelinating neuropathy and monoclonal IgM antibody to myelin‐associated glycoprotein. Neurology 33: 19–23. [DOI] [PubMed] [Google Scholar]
  • 51. Tatum AH (1993) Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM antimyelin‐associated glycoprotein. Ann Neurol 33: 502–506. [DOI] [PubMed] [Google Scholar]
  • 52. Umbricht D, Keusch G, Burger HR, Joller H, Fontana A (1987) [Essential cryoglobulinemia with glomerulonephritis as a variant of the purpura‐arthralgia‐nephritis syndrome]. Schweiz Med Wochenschr 117: 1723–1727. [PubMed] [Google Scholar]
  • 53. Valldeoriola F, Graus F, Steck AJ, Munoz E, de la Fuente M, Gallart T, Ribalta T, Bombi JA, Tolosa E (1993) Delayed appearance of anti‐myelin‐associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy. Ann Neurol 34: 394–396. [DOI] [PubMed] [Google Scholar]
  • 54. Vital C, Deminiere C, Bourgouin B, Lagueny A, David B, Loiseau P (1985) Waldenstrom's macroglobulinemia and peripheral neuropathy: deposition of M‐component and kappa light chain in the endoneurium. Neurology 35: 603–606. [DOI] [PubMed] [Google Scholar]
  • 55. Vital C, Deminiere C, Lagueny A, Bergouignan FX, Pellegrin JL, Doutre MS, Clement A, Beylot J (1988) Peripheral neuropathy with essential mixed cryoglobulinemia: biopsies from 5 cases. Acta Neuropathol (Berl) 75: 605–610. [DOI] [PubMed] [Google Scholar]
  • 56. Vital C, Gherardi R, Vital A, Kopp N, Pellissier JF, Soubrier M, Clavelou P, Bellance R, Delisle MB, Ruchoux MM, et al. (1994) Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M‐protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients. Acta Neuropathol (Berl) 87: 302–307. [DOI] [PubMed] [Google Scholar]
  • 57. Vital C, Vital A, Deminiere C, Julien J, Lagueny A, Steck AJ (1997) Myelin modifications in 8 cases of peripheral neuropathy with Waldenstrom's macroglobulinemia and anti‐MAG activity. Ultrastruct Pathol 21: 509–516. [DOI] [PubMed] [Google Scholar]
  • 58. Willison HJ (1994) Antiglycolipid antibodies in peripheral neuropathy: fact or fiction J Neurol Neurosurg Psychiatry 57: 1303–1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Zielasek J, Ritter G, Magi S, Hartung HP, Toyka KV (1994) A comparative trial of antiglycoconjugate antibody assays: IgM antibodies to GM 1. J Neurol 241: 475–480. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES